C85.9A
Non-Hodgkin lymphoma, unspecified, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Non-Hodgkin lymphoma (NHL) is a type of cancer that originates in the lymphatic system, part of the lymphatic and immune systems. When NHL is described as 'unspecified' and 'in remission,' it indicates that the specific subtype has not been determined or specified in detail, and that the cancer symptoms have subsided following treatment. Achieving remission means that signs and symptoms of cancer are reduced or disappear, but it does not necessarily mean the disease is cured. This condition might require ongoing monitoring to prevent potential relapse.
Causes & Symptoms
Clinical Causes: Genetic mutations or alterations in the DNA of lymphocytes Exposure to certain chemicals or pesticides Infections with certain viruses, such as Epstein-Barr virus (EBV) or Human T-cell lymphotropic virus (HTLV-1) Chronic immune system suppression or certain autoimmune diseases History of radiation therapy or chemotherapy Age, as NHL is more common in older adults
Key Symptoms: Swollen lymph nodes that are painless and persistent Unexplained weight loss Fever and night sweats Fatigue or weakness Loss of appetite Persistent itching Pain or pressure in affected areas, such as the abdomen or chest Frequent infections due to weakened immune function
Diagnostic & Treatment
Diagnosis Path: Diagnosis of Non-Hodgkin lymphoma involves a combination of clinical evaluation and diagnostic tests. These may include:
Treatment Protocols: Treatment strategies for Non-Hodgkin lymphoma in remission depend on the subtype and the patient's overall health. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is C85.9A a billable ICD-10 code?
Yes, C85.9A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C85.9A?
Clinical documentation must specify the nature of Non-Hodgkin lymphoma, unspecified, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference